Feb 02, 2022 9:25am EST Lexaria Reports Potentially Ground-Breaking Findings in Sildenafil Animal Study
Dec 29, 2021 11:15am EST Lexaria Receives Independent Review Board Approval For DehydraTECH-CBD Human Clinical Study HYPER-H21-4
Dec 08, 2021 7:30am EST Lexaria's DehydraTECHTM-CBD Reduces Arterial Stiffness, Results Confirmed in Human Clinical Study HYPER-H21-2
Nov 10, 2021 9:00am EST Lexaria 2022 R&D Programs to Include Investigations into Alzheimer's Disease and Diabetes
